Antigen-mediated T cell expansion regulated by parallel pathways of death

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 45, 2008, Pages 17463-17468

  Ch'en, Irene L ^a   Beisner, Daniel R ^a   Degterev, Alexei ^c   Lynch, Candace ^b   Yuan, Junying ^d   Hoffmann, Alexander ^b   Hedrick, Stephen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Autophagy; Necrosis; NF B; Ripk1

Indexed keywords

ANTIGEN; CARRIER PROTEINS AND BINDING PROTEINS; CASPASE 8; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN RIPK1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL DEATH; CELL EXPANSION; CONTROLLED STUDY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; CASPASE 8; CROSSES, GENETIC; FLOW CYTOMETRY; GENE SILENCING; MICE; MICE, INBRED C57BL; NECROSIS; NF-KAPPA B; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; T-LYMPHOCYTES;

EID: 56249132503     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0808043105     Document Type: Article

References (61)

1. Doherty PC, Christensen JP (2000) Accessing complexity: The dynamics of virus-specific T cell responses. Annu Rev Immunol 18:561-592.
2. Blattman JN, et al. (2002) Estimating the precursor frequency of naive antigen-specific CD8 T cells. J Exp Med 195:657-664.
3. De Boer RJ, Homann D, Perelson AS (2003) Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection. J Immunol 171:3928-3935.
4. Ameisen JC (2002) On the origin, evolution, and nature of programmed cell death: A timeline of four billion years. Cell Death Differ 9:367-393.
5. Green DR, Droin N, Pinkoski M (2003) Activation-induced cell death in T cells. Immunol Rev 193:70-81.
6. Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B (1997) Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276:2057-2062.
7. Brown IE, Mashayekhi M, Markiewicz M, Alegre ML, Gajewski TF (2005) Peripheral survival of naive CD8+ T cells. Apoptosis 10:5-11.
8. Boise LH, et al. (1995) CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3:87-98.
9. Razvi ES, Jiang Z, Woda BA, Welsh RM (1995) Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am J Pathol 147:79-91.
10. Murali-Krishna K, et al. (1998) Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 8:177-187.
11. Marrack P, Kappler J (2004) Control of T cell viability. Annu Rev Immunol 22:765-787.
12. Zhang J, Cado D, Chen A, Kabra NH, Winoto A (1998) Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392:296-300.
13. Newton K, Harris AW, Bath ML, Smith KGC, Strasser A (1998) A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J 17:706-718.
14. Walsh CM, et al. (1998) A role for FADD in T cell activation and development. Immunity 8:439-449.
15. Hueber AO, Zornig M, Bernard AM, Chautan M, Evan G (2000) A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts. J Biol Chem 275:10453-10462.
16. Chun HJ, et al. (2002) Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419:395-399.
17. Beisner DR, ChuIH, Arechiga AF, Hedrick SM, Walsh CM (2003) The requirements for Fas-associated death domain signaling in mature T cell activation and survival. J Immunol 171:247-256.
18. Salmena L, et al. (2003) Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 17:883-895.
19. Beisner DR, Ch'en IL, Kolla RV, Hoffmann A, Hedrick SM (2005) Cutting edge: Innate immunity conferred by B cells is regulated by caspase-8. J Immunol 175:3469-3473.
20. Lemmers B, et al. (2007) Essential role for caspase-8 in Toll-like receptors and NFκB signaling. J Biol Chem 282:7416-7423.
21. Imtiyaz HZ, et al. (2006) The Fas-associated death domain protein is required in apoptosis and TLR-induced proliferative responses in B cells. J Immunol 176:6852-6861.
22. Su H, et al. (2005) Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 307:1465-1468.
23. Dohrman A, et al. (2005) Cellular FLIP (Long Form) Regulates CD8+ T Cell Activation through Caspase-8-Dependent NF-κB Activation. J Immunol 174:5270-5278.
24. Misra RS, et al. (2007) Caspase-8 and c-FLIPL associate in lipid rafts with NF-κB adaptors during T cell activation. J Biol Chem 282:19365-19374.
25. Arechiga AF, et al. (2005) Cutting edge: FADD is not required for antigen receptor-mediated NF-κB activation. J Immunol 175:7800-7804.
26. Schulze-Osthoff K, Krammer PH, Droge W (1994) Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J 13:4587-4596.
27. Vercammen D, et al. (1998) Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187:1477-1485.
28. Matsumura H, et al. (2000) Necrotic death pathway in Fas receptor signaling. J Cell Biol 151:1247-1256.
29. Holler N, et al. (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1:489-495.
30. Degterev A, et al. (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112-119.
31. Noel PJ, Boise LH, Thompson CB (1996) Regulation of T cell activation by CD28 and CTLA4. Adv Exp Med Biol 406:209-217.
32. Cantrell D (2002) Protein kinase B (Akt) regulation and function in T lymphocytes. Semin Immunol 14:19-26.
33. Kane LP, Lin J, Weiss A (2002) It's all Rel-ative: NF-κB and CD28 costimulation of T-cell activation. Trends Immunol 23:413-420.
34. Zhang J, Kabra NH, Cado D, Kang C, Winoto A (2001) FADD-deficient T cells exhibit a disaccord in regulation of the cell cycle machinery. J Biol Chem 276:29815-29818.
35. Arechiga AF, et al. (2007) A Fas-associated death domain protein/caspase-8-signaling axis promotes S-phase entry and maintains S6 kinase activity in T cells responding to IL-2. J Immunol 179:5291-5300.
36. Festjens N, Vanden Berghe T, Vandenabeele P (2006) Necrosis, a well-orchestrated form of cell demise: Signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta 1757:1371-1387.
37. Golstein P, Kroemer G (2007) Cell death by necrosis: Towards a molecular definition. Trends Biochem Sci 32:37-43.
38. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ (1991) bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879-888.
39. Strasser A, Harris AW, Cory S (1991) bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889-899.
40. Chao DT, et al. (1995) Bcl-XL and Bcl-2 repress a common pathway of cell death. J Exp Med 182:821-828.
41. Liou HC, Baltimore D (1993) Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr Opin Cell Biol 5:477-487.
42. Hayden MS, Ghosh S (2004) Signaling to NF-κB. Genes Dev 18:2195-2224.
43. Werner SL, Barken D, Hoffmann A (2005) Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309:1857-1861.
44. Hoffmann A, Baltimore D (2006) Circuitry of nuclear factor κB signaling. Immunol Rev 210:171-186.
45. Degterev A, et al. (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol.
46. Stanger BZ, Leder P, Lee TH, Kim E, Seed B (1995) RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81:513-523.
47. Lin Y, Devin A, Rodriguez Y, Liu ZG (1999) Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 13:2514-2526.
48. Martinon F, Holler N, Richard C, Tschopp J (2000) Activation of a pro-apoptotic amplification loop through inhibition of NF-κB-dependent survival signals by caspase-mediated inactivation of RIP. FEBS Lett 468:134-136.
49. Kim JW, Choi EJ, Joe CO (2000) Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP. Oncogene 19:4491-4499.
50. Roulston A, Marcellus RC, Branton PE (1999) Viruses and apoptosis. Annu Rev Microbiol 53:577-628.
51. Aubert M, Jerome KR (2003) Apoptosis prevention as a mechanism of immune evasion. Int Rev Immunol 22:361-371.
52. Wan YY, DeGregori J (2003) The survival of antigen-stimulated T cells requires NFκB-mediated inhibition of p73 expression. Immunity 18:331-342.
53. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J (2001) NF-κB signals induce the expression of c-FLIP. Mol Cell Biol 21:5299-5305.
54. Khoshnan A, et al. (2000) The NF-κB cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J Immunol 165:1743-1754.
55. Falk M, et al. (2004) Caspase inhibition blocks human T cell proliferation by suppressing appropriate regulation of IL-2, CD25, and cell cycle-associated proteins. J Immunol 173:5077-5085.
56. Chau H, et al. (2005) Cellular FLICE-inhibitory protein is required for T cell survival and cycling. J Exp Med 202:405-413.
57. Arch RH, Thompson CB (1999) Lymphocyte survival: The struggle against death. Annu Rev Cell Dev Biol 15:113-140.
58. Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181-190.
59. Pyo JO, et al. (2005) Essential roles of Atg5 and FADD in autophagic cell death: Dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem 280:20722-20729.
60. Zarnegar B, et al. (2004) Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-κB activation pathways. Proc Natl Acad Sci USA 101:8108-8113.
61. Lin MY, Zal T, Ch'en IL, Gascoigne NR, Hedrick SM (2005) A pivotal role for the multifunctional calcium/calmodulin-dependent protein kinase II in T cells: From activation to unresponsiveness. J Immunol 174:5583-5592.